Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-007 + Sunitinib in Stage IV NSCLC
NCT00748163Phase 2Withdrawn
- Sponsor
- Masonic Cancer Center
- Start
- Aug 2008
- Primary completion
- Aug 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of nab-paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Masonic Cancer Center. Planned start Aug 2008; status: withdrawn.
02
Drugs
nab-paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00748163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748163.